Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-04-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 252 | $1.13 - $1.13 | $284 |
2024-04-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 90 | $1.13 - $1.13 | $101 |
2024-04-30 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $1.13 - $1.13 | $2,530 |
2024-04-21 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 7250 | $1.15 - $1.15 | $8,337 |
2024-04-21 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 2030 | $1.15 - $1.15 | $2,334 |
2024-04-21 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 19673 | $1.15 - $1.15 | $22,623 |
2024-03-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 252 | $1.20 - $1.20 | $302 |
2024-03-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 90 | $1.20 - $1.20 | $108 |
2024-03-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $1.20 - $1.20 | $2,686 |
2024-02-29 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 252 | $1.21 - $1.21 | $304 |
2024-02-29 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $1.21 - $1.21 | $2,709 |
2024-02-29 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 90 | $1.21 - $1.21 | $108 |
2024-02-18 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
A | Common Stock | A | 101743 | $0.00 - $0.00 | $0 |
2024-02-18 | NEUROONE MEDICAL TECHNOLOGIES Corp | McClurg Ronald W.
(Chief Financial Officer) |
A | Common Stock | A | 113717 | $0.00 - $0.00 | $0 |
2024-02-18 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
A | Common Stock | A | 25000 | $0.00 - $0.00 | $0 |
2024-02-18 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
A | Common Stock | A | 663497 | $0.00 - $0.00 | $0 |
2024-01-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Mertens Steve
(Chief Technology Officer) |
F | Common Stock | D | 252 | $1.25 - $1.25 | $315 |
2024-01-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Christianson Mark
(Business Development Director) |
F | Common Stock | D | 90 | $1.25 - $1.25 | $112 |
2024-01-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $1.25 - $1.25 | $2,798 |
2023-12-31 | NEUROONE MEDICAL TECHNOLOGIES Corp | Rosa David A
(CEO and President) |
F | Common Stock | D | 2239 | $1.58 - $1.58 | $3,537 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |